Literature DB >> 3454872

A pituitary-specific factor interacts with an upstream promotor element in the rat growth hormone gene.

D F Catanzaro1, B L West, J D Baxter, T L Reudelhuber.   

Abstract

The expression of the rat GH (rGH) gene is limited to the anterior pituitary. Using a DNase I footprinting assay, we have sought to identify specific protein-DNA interactions in the rGH 5'-flanking DNA that may be important in conferring tissue-specific use of the rGH promoter. We have identified a nuclear factor from rGH-secreting GC (rat pituitary) cells which interacts in the rGH 5'-flanking DNA between positions -94 to -62 relative to the start site of rGH gene transcription. This factor, which we have named GC1, is undetectable in nuclear extracts of non-rGH-producing rat fibroblast (Rat-2), or HeLa cells. Mutation of the GC1 binding region in the rGH 5'-flanking DNA results in only a small (30%) decrease in the ability of the rGH promoter to drive the expression of a linked marker gene when transfected into GC cells. GC1 represents, therefore, a novel type of promoter binding factor which is gene-specific and whose distribution is tissue-specific, but which is nonessential for the basal expression of its linked gene. Such a factor may, however, play a role in the modulation of rGH gene expression either through its interaction with other regulatory proteins or ligands or after enzyme modification.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3454872     DOI: 10.1210/mend-1-1-90

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  11 in total

1.  Characterization of a thyroid hormone receptor expressed in human kidney and other tissues.

Authors:  A Nakai; S Seino; A Sakurai; I Szilak; G I Bell; L J DeGroot
Journal:  Proc Natl Acad Sci U S A       Date:  1988-04       Impact factor: 11.205

Review 2.  The molecular basis of thyroid hormone action.

Authors:  L J DeGroot; A Nakai; A Sakurai; E Macchia
Journal:  J Endocrinol Invest       Date:  1989-12       Impact factor: 4.256

Review 3.  Regulation of gene expression by thyroid hormone.

Authors:  H H Samuels; B M Forman; Z D Horowitz; Z S Ye
Journal:  J Clin Invest       Date:  1988-04       Impact factor: 14.808

4.  Pituitary pro-opiomelanocortin gene expression requires synergistic interactions of several regulatory elements.

Authors:  M Therrien; J Drouin
Journal:  Mol Cell Biol       Date:  1991-07       Impact factor: 4.272

5.  Selective transcription and DNase I protection of the rat prolactin gene by GH3 pituitary cell-free extracts.

Authors:  A Gutierrez-Hartmann; S Siddiqui; S Loukin
Journal:  Proc Natl Acad Sci U S A       Date:  1987-08       Impact factor: 11.205

6.  Tissue-specific activity of the pro-opiomelanocortin gene promoter.

Authors:  L Jeannotte; M A Trifiro; R K Plante; M Chamberland; J Drouin
Journal:  Mol Cell Biol       Date:  1987-11       Impact factor: 4.272

7.  Differential binding of rat pituitary-specific nuclear factors to the 5'-flanking region of pituitary and placental members of the human growth hormone gene family.

Authors:  B E Nickel; M W Nachtigal; M E Bock; P A Cattini
Journal:  Mol Cell Biochem       Date:  1991-08-14       Impact factor: 3.396

8.  Human chorionic somatomammotropin and growth hormone gene expression in rat pituitary tumour cells is dependent on proximal promoter sequences.

Authors:  M W Nachtigal; B E Nickel; M E Klassen; W G Zhang; N L Eberhardt; P A Cattini
Journal:  Nucleic Acids Res       Date:  1989-06-12       Impact factor: 16.971

9.  Somatotroph- and lactotroph-specific interactions with the homeobox protein binding sites in the rat growth hormone gene promoter.

Authors:  F Schaufele; B L West; T Reudelhuber
Journal:  Nucleic Acids Res       Date:  1990-09-11       Impact factor: 16.971

10.  Tamoxifen inhibits transforming growth factor-alpha gene expression in human breast carcinoma samples treated with triiodothyronine.

Authors:  S J Conde; R A M Luvizotto; M T Síbio; M L H Katayama; M M Brentani; C R Nogueira
Journal:  J Endocrinol Invest       Date:  2008-12       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.